Boill Healthcare (01246) releases annual performance results, with a net loss of HK$194 million for shareholders, a decrease of 76.61% compared to the previous year.

Boill Healthcare (01246) announced its annual performance for the year ending March 31, 2026, with the group achieving revenue of HK$258 million, a year-on-year increase of 234.82%. The company's attributable loss was HK$194 million, a year-on-year decrease of 76.61%, with a loss per share of 14.29 HK cents. For the fiscal year ending 2026, the overall performance of the group was not as expected, mainly due to a net loss provision of approximately HK$49.3 million for the development-in-progress property of the comprehensive industrial park project (2025 fiscal year: HK$299.5 million).